Exciting announcement for the Centre for Biological Applications of Mass Spectrometry (CBAMS)
Concordia has recently joined forces with the The Metabolomics Innovation Centre, Canada’s leading platform for metabolomics research, training, and services.
Metabolomics is the science of measuring hundreds to thousands of small metabolites in a biological sample in a single analysis. This technology provides an unprecedented level of metabolic information with applications in a wide range of fields including precision medicine, drug discovery, nutrition, environmental sciences, food and agriculture.
Thanks to the generous support of the Canada Foundation for Innovation, Concordia has become one of the centre's nine research nodes across Canada.
Dajana Vuckovic, associate professor in the Department of Chemistry and Biochemistry and director of CBAMS at Concordia, has been appointed as one of the three new node leaders, solidifying her position as one of the country's foremost experts in metabolomics.
Vuckovic's group at Concordia specializes in developing new mass spectrometry methods and devices to improve metabolite coverage and data quality in metabolomics. Their primary focus is on the discovery and validation of personalized biomarkers in cardiovascular health and nutrition. Her lab has also built highly sensitive assays for mycotoxin biomonitoring, including the largest in-house library of human mycotoxin metabolites that includes 100 metabolites characterized for the first time.
To learn more about the services offered by CBAMS and how you can access them, please visit the centre's website.